GURU
发表于 2025-3-21 16:24:10
书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0587517<br><br> <br><br>书目名称Living with Chronic Disease: Measuring Important Patient-Reported Outcomes读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0587517<br><br> <br><br>
Yag-Capsulotomy
发表于 2025-3-21 20:46:28
http://image.papertrans.cn/l/image/587517.jpg
推延
发表于 2025-3-22 01:10:59
http://reply.papertrans.cn/59/5876/587517/587517_3.png
OVER
发表于 2025-3-22 04:56:47
978-981-13-4143-4Springer Nature Singapore Pte Ltd. 2018
Hemiplegia
发表于 2025-3-22 11:45:46
http://reply.papertrans.cn/59/5876/587517/587517_5.png
Exclude
发表于 2025-3-22 16:58:12
Conceptualisation and Qualitative Development of a PRO Measured pretesting the tool (Step V). Chapter . will outline procedures for assessing the performance of a new PROs against expectation (Step VI), and Chap. . will present a framework for integrating the conventional approach with more advanced techniques to fine-tune the tool (Step VII).
fleeting
发表于 2025-3-22 19:52:24
Integrating PRO Assessment in Clinical Trials, Routine Clinical Practice and Medicines Development Pative care and chronic pain clinics, and second, perspectives of industry executives and regulators on PROs. We conclude the chapter, with some recommendations on enhancing the application of PRO assessments across different settings.
preservative
发表于 2025-3-22 23:30:50
Overviewsponse by a clinician or anyone else (US Food and Drug Administration 2009). Examples include patient’s report of their symptoms, physical function or patient satisfaction. However, emphasis on the patient’s own self-report has increased in the last two decades.
策略
发表于 2025-3-23 02:15:24
http://reply.papertrans.cn/59/5876/587517/587517_9.png
手段
发表于 2025-3-23 05:49:20
http://reply.papertrans.cn/59/5876/587517/587517_10.png